Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain
Abstract
The anatomical distribution and density of cannabinoid receptors in the human brain was studied in one fetal (33 weeks gestation), two neonatal (aged three to six months) and eight adult (aged 21-81 years) human cases using quantitative receptor autoradiography following in vitro labelling of sections with the synthetic cannabinoid agonist [3H]CP55,940. Cannabinoid receptors were distributed in a heterogeneous fashion throughout the adult human brain and spinal cord. The allocortex contained very high concentrations of cannabinoid receptor binding sites in the dentate gyrus, Ammons's horn and subiculum of the hippocampal formation; high concentrations of receptors were also present in the entorhinal cortex and amygdaloid complex. Cannabinoid receptor binding sites were also present throughout all regions of the neocortex, where they showed a marked variation in density between the primary, secondary and associational cortical regions: the greatest densities of receptors were present in the associational cortical regions of the frontal and limbic lobes, with moderate densities in the secondary sensory and motor cortical regions, and with the lowest densities of receptors in the primary sensory and motor cortical regions. Relatively high concentrations of cannabinoid receptors were consistently seen in cortical regions of the left (dominant) hemisphere, known to be associated with verbal language functions. In all of the cortical regions, the pattern and density of receptor labelling followed the neocortical laminar organization, with the greatest density of receptors localized in two discrete bands--a clearly delineated narrow superficial band which coincided with lamina I and a deeper broader, conspicuous band of labelling which corresponded to laminae V and VI. Labelling in the intervening cortical laminae (II-IV) showed lower densities, with a well delineated narrow band of label in the middle of laminae IV in the associational cortical regions. The thalamus showed a distinctive heterogeneous distribution of cannabinoid receptors, with the highest concentration of receptors localized in the mediodorsal nucleus, anterior nuclear complex, and in the midline and intralaminar complex of nuclei, i.e. in thalamic nuclei which have connectional affiliations with the associational cortical areas. The basal ganglia showed a distinctive heterogeneous pattern of receptor binding, with the very highest concentrations in the globus pallidus internus, moderate concentrations in the globus pallidus externus and ventral pallidum, and moderately low levels of binding throughout the striatal complex. In the midbrain, some of the highest levels of cannabinoid receptor binding sites in the human brain were present in the substantia nigra pars reticulata, with very low levels of labelling in all other midbrain areas. The highest densities of cannabinoid receptor binding in the hindbrain were localized in the molecular layer of the cerebellar cortex and the dorsal motor nucleus of the vagus, with moderate densities of receptors in the nucleus of the solitary tract. The spinal cord showed very low levels of receptor binding. Studies on the distribution of cannabinoid receptors in the fetal and neonatal human brain showed similar patterns of receptor distribution to that observed in the adult human brain, except that the density of receptor binding was generally markedly higher, especially in the basal ganglia and substantia nigra. The pattern of cannabinoid receptor labelling in the striatum showed a striking patchy pattern of organization which was especially conspicuous in the fetal brain. These results show that cannabinoid receptor binding sites in the human brain are localized mainly in: forebrain areas associated with higher cognitive functions; forebrain, midbrain and hindbrain areas associated with the control of movement; and in hindbrain areas associated with the control of motor and sensory functions of the autonomic nervous system. (AB
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
CB1 receptors are the most abundant G-protein-coupled receptors in the central nervous system.
“CB1 receptors are the most abundant G-protein-coupled receptors in the central nervous system12, 13”
From Elevated brain cannabinoid CB1 receptor availability in post-traumatic stress disorder: A positron emission tomography study (2013) · cites this paper as [12]
Cites
Isolation and Structure of a Brain Constituent That Binds to the Cannabinoid Receptor
Devane, W. A., Hanuš, L., Breuer, A., Pertwee, R. G., Stevenson, L. A., Griffin, G., Gibson, D., Mandelbaum, A., Etinger, A., & Mechoulam, R. (1992) · Science · doi:10.1126/science.1470919 · Cited by 5,633 · see citing works
Structure of a cannabinoid receptor and functional expression of the cloned cDNA
Matsuda, L. A., Lolait, S. J., Brownstein, M. J., Young, A. C., & Bonner, T. I. (1990) · Nature · doi:10.1038/346561a0 · Cited by 5,011 · see citing works
Isolation, Structure, and Partial Synthesis of an Active Constituent of Hashish
Gaoni, Y., & Mechoulam, R. (1964) · Journal of the American Chemical Society · doi:10.1021/ja01062a046 · Cited by 2,389 · see citing works
Cannabinoid receptor localization in brain.
Herkenham, M., Lynn, A. B., Little, M. D., Johnson, M. R., Melvin, L. S., de Costa, B. R., & Rice, K. C. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.5.1932 · Cited by 2,321 · see citing works
Herkenham, M., Lynn, A., Johnson, M., Melvin, L., de Costa, B., & Rice, K. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-02-00563.1991 · Cited by 2,159 · see citing works
Jones, E. G. (1985) · Springer eBooks · doi:10.1007/978-1-4615-1749-8 · Cited by 1,164 · see citing works
Graybiel, A. M., & Ragsdale, C. W. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.11.5723 · Cited by 784 · see citing works
Laminar organization of thalamic projections to the rat neocortex.
Herkenham, M. (1980) · Science · doi:10.1126/science.7352263 · Cited by 579 · see citing works
Neuronal localization of cannabinoid receptors in the basal ganglia of the rat
Herkenham, M. A., Lynn, A. B., de Costa, B. R., & Richfield, E. K. (1991) · Brain Research · doi:10.1016/0006-8993(91)90970-7 · Cited by 515 · see citing works
Hollister, L. E. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90030-4 · Cited by 500 · see citing works
Dewey, W. L. (1987) · Journal of Ethnopharmacology · doi:10.1016/0378-8741(87)90061-4 · Cited by 379 · see citing works
Howlett, A. C., & Fleming, R. M. (1984) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)15066-9 · Cited by 376 · see citing works
Presence of cannabinoid binding sites in the brain from early postnatal ages
de Fonseca, F. R., Ramos, J. A., Bonnin, A., & Fernández‐Ruíz, J. (1993) · Neuroreport · doi:10.1097/00001756-199302000-00005 · Cited by 297 · see citing works
Pharmacology and stereoselectivity of structurally novel cannabinoids in mice.
Little, P., Compton, D. M., Johnson, M. R., Melvin, L. S., & Martin, B. R. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13256-4 · Cited by 290 · see citing works
Westlake, T. M., Howlett, A., Bonner, T., Matsuda, L., & Herkenham, M. (1994) · Neuroscience · doi:10.1016/0306-4522(94)90511-8 · Cited by 290 · see citing works
Correspondence between the Dopamine islands and striosomes of the mammalian striatum
Graybiel, A. M. (1984) · Neuroscience · doi:10.1016/0306-4522(84)90293-8 · Cited by 282 · see citing works
Howlett, A. C., Johnson, M. R., Melvin, L. S., & Milne, G. M. (1988) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)13196-9 · Cited by 253 · see citing works
Heyser, C. J., Hampson, R. E., & Deadwyler, S. A. (1993) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)10268-1 · Cited by 245 · see citing works
Decreased Neuronal and Increased Oligodendroglial Densities in Huntington's Disease Caudate Nucleus
Myers, R. H., Vonsattel, J. P., Paskevich, P. A., Kiely, D. K., Stevens, T. J., Cupples, L. A., Richardson, E. P., & Bird, E. D. (1991) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199111000-00005 · Cited by 239 · see citing works
Loss of cannabinoid receptors in the substantia nigra in huntington's disease
Glass, M., Faull, R. L. M., & Dragunow, M. (1993) · Neuroscience · doi:10.1016/0306-4522(93)90352-g · Cited by 230 · see citing works
Self-citationCannabinoid Receptors and Modulation of Cyclic AMP Accumulation in the Rat Brain
Bidaut‐Russell, M., Devane, W. A., & Howlett, A. C. (1990) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1990.tb08815.x · Cited by 208 · see citing works
The Marihuana Problem: An Overview
McGlothlin, W. H., & West, L. J. (1968) · American Journal of Psychiatry · doi:10.1176/ajp.125.3.370 · Cited by 195 · see citing works
Representation in the hippocampus: what do hippocampal neurons code?
Eichenbaum, H., & Cohen, N. J. (1988) · Trends in Neurosciences · doi:10.1016/0166-2236(88)90100-2 · Cited by 184 · see citing works
Psychopharmacological activity of the active constituents of hashish and some related cannabinoids
Grunfeld, Y., & Edery, H. (1969) · Psychopharmacology · doi:10.1007/bf00404218 · Cited by 183 · see citing works
Richfield, E. K., & Herkenham, M. A. (1994) · Annals of Neurology · doi:10.1002/ana.410360406 · Cited by 177 · see citing works
Inhibition of neuroblastoma adenylate cyclase by cannabinoid and nantradol compounds
Howlett, A. C. (1984) · Life Sciences · doi:10.1016/0024-3205(84)90278-9 · Cited by 150 · see citing works
Cannabis: Effects on memory and the cholinergic limbic system.
Miller, L. L., & Branconnier, R. J. (1983) · Psychological Bulletin · doi:10.1037/0033-2909.93.3.441 · Cited by 136 · see citing works
de Fonseca, F. R., Cebeira, M., Fernández‐Ruíz, J., Navarro, M. A., & Ramos, J. A. (1991) · Neuroscience · doi:10.1016/0306-4522(91)90329-m · Cited by 126 · see citing works
Schulze, G. E., McMillan, D. E., Bailey, J. R., Scallet, A. C., Ali, S. F., Slikker, W., & Paule, M. G. (1988) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)22284-4 · Cited by 124 · see citing works
Cellular Processes of Learning and Memory in the Mammalian CNS
Thompson, R. F., Berger, T. W., & Madden, J. J. (1983) · Annual Review of Neuroscience · doi:10.1146/annurev.ne.06.030183.002311 · Cited by 124 · see citing works
Mailleux, P., & Vanderhaeghen, J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90832-r · Cited by 122 · see citing works
Comparative effects of smoking marihuana or placebo on human motor and mental performance
Manno, J. E., Kiplinger, G. F., Haine, S. E., Bennett, I. F., & Forney, R. B. (1970) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt1970116808 · Cited by 118 · see citing works
Graybiel, A. M., & Ragsdale, C. W. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.2.1214 · Cited by 105 · see citing works
Identification of cannabinoid receptors in cultures of rat cerebellar granule cells
Pacheco, M. A., Ward, S. J., & Childers, S. R. (1993) · Brain Research · doi:10.1016/0006-8993(93)91304-b · Cited by 98 · see citing works
Howlett, A. C. (1987) · Neuropharmacology · doi:10.1016/0028-3908(87)90035-9 · Cited by 95 · see citing works
Dorsal motor nucleus of the vagus nerve: A cyto‐ and chemoarchitectonic study in the human
Huang, X., Törk, I., & Paxinos, G. (1993) · The Journal of Comparative Neurology · doi:10.1002/cne.903300203 · Cited by 95 · see citing works
Review of cannabinoids and their antiemetic effectiveness
Vincent, B. J., McQuiston, D. J., Einhorn, L. H., Nagy, C. M., & Brames, M. J. (1983) · Drugs · doi:10.2165/00003495-198300251-00006 · Cited by 83 · see citing works
Acute Effects of Marihuana on Speech
Weil, A., & Zinberg, N. E. (1969) · Nature · doi:10.1038/222434a0 · Cited by 82 · see citing works
Toxic Effects of Chronic Marihuana Use
Kolansky, H. (1972) · JAMA · doi:10.1001/jama.1972.03210010017004 · Cited by 81 · see citing works
Paule, M. G., Allen, R. R., Bailey, J. R., Scallet, A. C., Ali, S. F. A., Brown, R. M., & Slikker, W. (1992) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)11218-4 · Cited by 70 · see citing works
Faull, R. L. M., Dragunow, M., & Villiger, J. W. (1989) · Brain Research · doi:10.1016/0006-8993(89)90735-x · Cited by 66 · see citing works
Self-citationCatalepsy induced by intrastriatal injections of Δ9-THC and 11-OH-Δ9-THC in the rat
Gough, A. L., & Olley, J. E. (1978) · Neuropharmacology · doi:10.1016/0028-3908(78)90126-0 · Cited by 60 · see citing works
Developmental expression of cannabinoid receptor mRNA
McLaughlin, C. R., & Abood, M. E. (1993) · Developmental Brain Research · doi:10.1016/0165-3806(93)90124-s · Cited by 58 · see citing works
Faull, R. L. M., & Villiger, J. W. (1988) · Neuroscience · doi:10.1016/0306-4522(88)90340-5 · Cited by 58 · see citing works
Self-citationOperant acquisition of marihuana by women.
Mello, N. K., & Mendelson, J. H. (1985) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23850-2 · Cited by 55 · see citing works
Operant acquisition of marihuana in man.
Mendelson, J. H., Kuehnle, J. C., Greenberg, I., & Mello, N. K. (1976) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)30570-7 · Cited by 53 · see citing works
Suppression of Cancer Chemotherapy-Induced Vomiting in the Cat by Nabilone, a Synthetic Cannabinoid
London, S., McCarthy, L. E., & Borison, H. L. (1979) · Experimental Biology and Medicine · doi:10.3181/00379727-160-40465 · Cited by 53 · see citing works
Compartmentalization of parvalbumin immunoreactivity in the human striatum
Waldvogel, H. J., & Faull, R. L. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)91415-o · Cited by 48 · see citing works
Self-citationMoss, D. E., Manderscheid, P. Z., Montgomery, S. P., Norman, A. B., & Sanberg, P. R. (1989) · Life Sciences · doi:10.1016/0024-3205(89)90444-x · Cited by 45 · see citing works
Faull, R. L. M., & Villiger, J. W. (1986) · Brain Research · doi:10.1016/0006-8993(86)90704-3 · Cited by 36 · see citing works
Self-citationChanges in brain dopaminergic indices induced by perinatal exposure to cannabinoids in rats
de Fonseca, F. R., Cebeira, M., Hernández, M., Ramos, J. A., & Fernández‐Ruíz, J. (1990) · Developmental Brain Research · doi:10.1016/0165-3806(90)90280-c · Cited by 34 · see citing works
MARIJUANA AND MEMORY: EFFECTS OF SMOKING ON STORAGE*
Dornbush, R. L. (1974) · Transactions of the New York Academy of Sciences · doi:10.1111/j.2164-0947.1974.tb01557.x · Cited by 34 · see citing works
THE RELATIVE ACTIVITY OF VARIOUS PURIFIED PRODUCTS OBTAINED FROM AMERICAN GROWN HASHISH
WALTON, R. P., Martin, L., & KELLER, J. H. (1938) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)09020-2 · Cited by 34 · see citing works
MOTIVATIONAL EFFECTS OF SMOKED MARIJUANA: BEHAVIORAL CONTINGENCIES AND LOW‐PROBABILITY ACTIVITIES
Foltin, R. W., Fischman, M. W., Brady, J. V., Bernstein, D. J., Capriotti, R. M., Nellis, M. J., & Kelly, T. H. (1990) · Journal of the Experimental Analysis of Behavior · doi:10.1901/jeab.1990.53-5 · Cited by 33 · see citing works
Campbell, K. A., Foster, T. C., Hampson, R. E., & Deadwyler, S. A. (1986) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)23359-6 · Cited by 30 · see citing works
Impaired speed of visual information processing in marijuana intoxication
Braff, D. L., Silverton, L., Saccuzzo, D. P., & Janowsky, D. S. (1981) · American Journal of Psychiatry · doi:10.1176/ajp.138.5.613 · Cited by 27 · see citing works
The Discovery of Nonclassical Cannabinoid Analgetics
Johnson, M. R., & Melvin, L. S. (2019) · Chapman & Hall/CRC eBooks · doi:10.1201/9780429260667-7 · Cited by 22 · see citing works
Mailleux, P., Verslijpe, M., & Vanderhaeghen, J. (1992) · Neuroscience Letters · doi:10.1016/0304-3940(92)90845-x · Cited by 21 · see citing works
Changes in hippocampal CA1 population spikes following administration of delta-9-THC
Weisz, D. J., Gunnell, D., Teyler, T. J., & Vardaris, R. M. (1982) · Brain Research Bulletin · doi:10.1016/0361-9230(82)90042-9 · Cited by 20 · see citing works
Kujtan, P. W., Carlen, P. L., & Kapur, B. M. (1983) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y83-063 · Cited by 17 · see citing works
Is the pharmacological treatment of cancer cachexia possible?
Bruera, E. D. (1993) · Supportive Care in Cancer · doi:10.1007/bf00364967 · Cited by 16 · see citing works
A MODEL OF ATTENTION DESCRIBING THE COGNITIVE EFFECTS OF MARIJUANA
Delong, F. L., & LEVY, B. I. (1974) · Elsevier eBooks · doi:10.1016/b978-0-12-497050-2.50010-3 · Cited by 4 · see citing works
US stalls over tests of marijuana to treat AIDS patients
Lehrman, S. (1995) · Nature · doi:10.1038/374007b0 · Cited by 2 · see citing works
Darley, C. F., & Tinklenberg, J. R. (1974) · Elsevier eBooks · doi:10.1016/b978-0-12-497050-2.50009-7 · Cited by 2 · see citing works
Flagged first, then by citations
4 of the 68 references couldn’t be matched to a known paper.
Cited by
Sorted by citations
International Union of Pharmacology. XXVII. Classification of Cannabinoid Receptors
Howlett, A. C., Barth, F., Bonner, T. I., Cabral, G., Casellas, P., Devane, W. A., Felder, C. C., Herkenham, M., Mackie, K., Martin, B. R., et al. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.161 · Cited by 2,819 · see citing works
The Endocannabinoid System as an Emerging Target of Pharmacotherapy
Pacher, P., Bátkai, S., & Kunos, G. (2006) · Pharmacological Reviews · doi:10.1124/pr.58.3.2 · Cited by 2,077 · see citing works
Role of Endogenous Cannabinoids in Synaptic Signaling
Freund, T. F., Katona, I., & Piomelli, D. (2003) · Physiological Reviews · doi:10.1152/physrev.00004.2003 · Cited by 1,567 · see citing works
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293 · see citing works
D'Souza, D. C., Perry, E., MacDougall, L., Ammerman, Y., Cooper, T., Wu, Y.-T., Braley, G., Gueorguieva, R., & Krystal, J. H. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300496 · Cited by 1,024 · see citing works
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Pagotto, U., Marsicano, G., Cota, D., Lutz, B., & Pasquali, R. (2005) · Endocrine Reviews · doi:10.1210/er.2005-0009 · Cited by 856 · see citing works
The effects of cannabinoids on the brain
Ameri, A. (1999) · Progress in Neurobiology · doi:10.1016/s0301-0082(98)00087-2 · Cited by 805 · see citing works
Ramírez, B. G., Blázquez, C., del Pulgar, T. G., Guzmán, M., & CEBALLOS, M. L. D. (2005) · Journal of Neuroscience · doi:10.1523/jneurosci.4540-04.2005 · Cited by 785 · see citing works
Distribution of cannabinoid receptors in the central and peripheral nervous system
Mackie, K. (2005) · Handbook of Experimental Pharmacology · doi:10.1007/3-540-26573-2_10 · Cited by 744 · see citing works
Cannabinoid receptors and pain
Pertwee, R. G. (2001) · Progress in Neurobiology · doi:10.1016/s0301-0082(00)00031-9 · Cited by 741 · see citing works
Functional anatomy of thalamus and basal ganglia
Herrero, M.-T., Barcia, C., & Navarro, J. (2002) · Child s Nervous System · doi:10.1007/s00381-002-0604-1 · Cited by 660 · see citing works
Glass, M., & Felder, C. C. (1997) · Journal of Neuroscience · doi:10.1523/jneurosci.17-14-05327.1997 · Cited by 634 · see citing works
Self-citationHistory of Cannabis and Its Preparations in Saga, Science, and Sobriquet
Russo, E. B. (2007) · Chemistry & Biodiversity · doi:10.1002/cbdv.200790144 · Cited by 630 · see citing works
Benito, C., Núñez, E., Tolón, R. M., Carrier, E. J., Rábano, A., Hillard, C. J., & Romero, J. (2003) · Journal of Neuroscience · doi:10.1523/jneurosci.23-35-11136.2003 · Cited by 624 · see citing works
D’Souza, D. C., Abi-Saab, W. M., Madonick, S., Forselius-Bielen, K., Doersch, A., Braley, G., Gueorguieva, R., Cooper, T. B., & Krystal, J. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2004.12.006 · Cited by 617 · see citing works
Cannabinoid physiology and pharmacology: 30 years of progress
Howlett, A. C., Breivogel, C. S., Childers, S. R., Deadwyler, S. A., Hampson, R. E., & Porrino, L. J. (2004) · Neuropharmacology · doi:10.1016/j.neuropharm.2004.07.030 · Cited by 608 · see citing works
Hirvonen, J., Goodwin, R. S., Li, C.-T., Terry, G. E., Zoghbi, S. S., Morse, C., Pike, V. W., Volkow, N. D., Huestis, M. A., & Innis, R. B. (2012) · Molecular Psychiatry · doi:10.1038/mp.2011.82 · Cited by 587 · see citing works
Glass, M., Dragunow, M., & Faull, R. L. M. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00008-7 · Cited by 525 · see citing works
Self-citationCristino, L., PETROCELLIS, L. D., Pryce, G., Baker, D., Guglielmotti, V., & Marzo, V. D. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.02.074 · Cited by 489 · see citing works
Endocannabinoid system and stress and anxiety responses
VIVEROS, M., MARCO, E., & FILE, S. (2005) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2005.01.029 · Cited by 485 · see citing works
Giuffrida, A., Leweke, F. M., Gerth, C. W., Schreiber, D., Koethe, D., Faulhaber, J., Klosterkötter, J., & Piomelli, D. (2004) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300558 · Cited by 481 · see citing works
Huestis, M. A., Gorelick, D. A., Heishman, S. J., Preston, K. L., Nelson, R. A., Moolchan, E. T., & Frank, R. A. (2001) · Archives of General Psychiatry · doi:10.1001/archpsyc.58.4.322 · Cited by 479 · see citing works
Hermanns‐Clausen, M., Kneisel, S., Szabó, B., & Auwärter, V. (2012) · Addiction · doi:10.1111/j.1360-0443.2012.04078.x · Cited by 478 · see citing works
Endocannabinoid signalling in reward and addiction
Parsons, L. H., & Hurd, Y. L. (2015) · Nature reviews. Neuroscience · doi:10.1038/nrn4004 · Cited by 474 · see citing works
Huizink, A. C., & Mulder, E. J. H. (2006) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.04.005 · Cited by 468 · see citing works
Svíženská, I. H., Dubový, P., & Šulcová, A. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.05.010 · Cited by 459 · see citing works
Elevated endogenous cannabinoids in schizophrenia
Leweke, F. M., Giuffrida, A., Wurster, U., Emrich, H. M., & Piomelli, D. (1999) · Neuroreport · doi:10.1097/00001756-199906030-00008 · Cited by 431 · see citing works
Schneider, M., & Koch, M. (2003) · Neuropsychopharmacology · doi:10.1038/sj.npp.1300225 · Cited by 425 · see citing works
Demuth, D. G., & Molleman, A. (2005) · Life Sciences · doi:10.1016/j.lfs.2005.05.055 · Cited by 423 · see citing works
Dietrich, A., & McDaniel, W. F. (2004) · British Journal of Sports Medicine · doi:10.1136/bjsm.2004.011718 · Cited by 410 · see citing works
CANNABINOID RECEPTORS AND THEIR ENDOGENOUS AGONISTS
Felder, C. C., & Glass, M. (1998) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.38.1.179 · Cited by 410 · see citing works
Self-citationBrain cannabinoid CB2 receptors modulate cocaine's actions in mice
Xi, Z.-X., Peng, X.-Q., Li, X., Song, R., Zhang, H.-Y., Liu, Q.-R., Yang, H.-J., Bi, G.-H., Li, J., & Gardner, E. L. (2011) · Nature Neuroscience · doi:10.1038/nn.2874 · Cited by 397 · see citing works
CB 1 and CB 2 Receptor Pharmacology
Howlett, A. C., & Abood, M. E. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.007 · Cited by 385 · see citing works
Dean, B., Sundram, S., Bradbury, R., Scarr, E., & Copolov, D. (2001) · Neuroscience · doi:10.1016/s0306-4522(00)00552-2 · Cited by 381 · see citing works
Keep off the grass? Cannabis, cognition and addiction
Curran, H. V., Freeman, T. P., Mokrysz, C., Lewis, D. A., Morgan, C. J. A., & Parsons, L. H. (2016) · Nature reviews. Neuroscience · doi:10.1038/nrn.2016.28 · Cited by 381 · see citing works
Endocannabinoid signalling and the deteriorating brain
Marzo, V. D., Stella, N., & Zimmer, A. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3876 · Cited by 381 · see citing works
Neural substrates of faulty decision-making in abstinent marijuana users
Bolla, K. I., Eldreth, D. A., Matochik, J. A., & Cadet, J. L. (2005) · NeuroImage · doi:10.1016/j.neuroimage.2005.02.012 · Cited by 378 · see citing works
Neumeister, A., Normandin, M. D., Pietrzak, R. H., Piomelli, D., Zheng, M. Q., Gujarro-Anton, A., Potenza, M. N., Bailey, C. R., Lin, S. F., Najafzadeh, S., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.61 · Cited by 361 · see citing works
Lymphocytes as a neural probe: potential for studying psychiatric disorders
Gladkevich, A. V., Kauffman, H. F., & Korf, J. (2004) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2004.01.009 · Cited by 359 · see citing works
Kearn, C. S., Blake-Palmer, K. G., Daniel, E., Mackie, K., & Glass, M. (2005) · Molecular Pharmacology · doi:10.1124/mol.104.006882 · Cited by 358 · see citing works
Self-citationJaggar, S., Hasnie, F. S., Sellaturay, S., & Rice, A. S. C. (1998) · Pain · doi:10.1016/s0304-3959(98)00041-4 · Cited by 351 · see citing works
The endogenous cannabinoid system and brain development
Fernández‐Ruíz, J., Berrendero, F., Hernández, M., & Ramos, J. A. (2000) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01491-5 · Cited by 345 · see citing works
Bossong, M. G., & Niesink, R. J. M. (2010) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.06.010 · Cited by 333 · see citing works
Effect of long-term cannabis use on axonal fibre connectivity
Zalesky, A., Solowij, N., Yücel, M., Lubman, D. I., Takagi, M., Harding, I. H., Lorenzetti, V., Wang, R., Searle, K., Pantelis, C., et al. (2012) · Brain · doi:10.1093/brain/aws136 · Cited by 327 · see citing works
Burns, H. D., Laere, K. V., Bohorquez, S. M. S., Hamill, T. G., Bormans, G. M., Eng, W., Gibson, R. E., Ryan, C. N., Connolly, B., Patel, S., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703472104 · Cited by 317 · see citing works
Exercise activates the endocannabinoid system
Sparling, P. B., Giuffrida, A., Piomelli, D., Rosskopf, L., & Dietrich, A. (2003) · Neuroreport · doi:10.1097/00001756-200312020-00015 · Cited by 313 · see citing works
Endogenous cannabinoid system as a modulator of food intake
Cota, D., Marsicano, G., Lutz, B., Vicennati, V., Stalla, G. K., Pasquali, R., & Pagotto, U. (2003) · International Journal of Obesity · doi:10.1038/sj.ijo.0802250 · Cited by 313 · see citing works
A literature review of the consequences of prenatal marihuana exposure
Fried, P. A., & Smith, A. (2001) · Neurotoxicology and Teratology · doi:10.1016/s0892-0362(00)00119-7 · Cited by 308 · see citing works
The Endocannabinoid System: A Potential Target for the Treatment of Various Diseases
Lowe, H., Toyang, N., Steele, B., Bryant, J., & Ngwa, W. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179472 · Cited by 303 · see citing works
Cannabinoid 1 receptors are expressed in nociceptive primary sensory neurons
Ahluwalia, J. P., Urbán, L., Capogna, M., Bevan, S., & Nagy, I. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00389-4 · Cited by 302 · see citing works
Cannabinoid receptors and the regulation of immune response
Berdyshev, E. V. (2000) · Chemistry and Physics of Lipids · doi:10.1016/s0009-3084(00)00195-x · Cited by 280 · see citing works
Muller-Vahl, K. R., Schneider, U., Prevedel, H., Theloe, K., Kolbe, H., Daldrup, T., & Emrich, H. M. (2003) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v64n0417 · Cited by 270 · see citing works
McPartland, J., Glass, M., & Pertwee, R. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707399 · Cited by 266 · see citing works
Self-citationZavitsanou, K., Garrick, T. M., & Huang, X. (2003) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2003.11.005 · Cited by 264 · see citing works
Genetics and Neuropathology of Huntington's Disease
Reiner, A. J., Dragatsis, I., & Dietrich, P. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00014-6 · Cited by 262 · see citing works
A systematic review of the antipsychotic properties of cannabidiol in humans
Iseger, T. A., & Bossong, M. G. (2015) · Schizophrenia Research · doi:10.1016/j.schres.2015.01.033 · Cited by 261 · see citing works
Eggan, S. M., & Lewis, D. A. (2006) · Cerebral Cortex · doi:10.1093/cercor/bhj136 · Cited by 261 · see citing works
Cannabinoids, the endocannabinoid system, and pain: a review of preclinical studies
Finn, D. P., Haroutounian, S., Hohmann, A. G., Krane, E. J., Soliman, N., & Rice, A. S. C. (2021) · Pain · doi:10.1097/j.pain.0000000000002268 · Cited by 262 · see citing works
Altered brain tissue composition in heavy marijuana users
Matochik, J. A., Eldreth, D. A., Cadet, J.-L., & Bolla, K. I. (2004) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2004.06.011 · Cited by 260 · see citing works
Cannabinoids and the immune system: Potential for the treatment of inflammatory diseases?
Croxford, J. L., & Yamamura, T. (2005) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2005.04.023 · Cited by 256 · see citing works
Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review
Sarris, J., Sinclair, J., Karamacoska, D., Davidson, M., & Firth, J. (2020) · BMC Psychiatry · doi:10.1186/s12888-019-2409-8 · Cited by 253 · see citing works
Neurocognitive consequences of marihuana—a comparison with pre-drug performance
Fried, P. A., Watkinson, B., & Gray, R. (2004) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2004.11.003 · Cited by 252 · see citing works
The Influence of Marijuana Use on Neurocognitive Functioning in Adolescents
Tapert, S. F., Schweinsburg, A. D., & Brown, S. A. (2008) · Current Drug Abuse Reviews · doi:10.2174/1874473710801010099 · Cited by 252 · see citing works
Cannabinoid Transmission and Reward-Related Events
Gardner, E. L., & Vorel, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0219 · Cited by 247 · see citing works
Screening of selected indigenous plants of Lebanon for antimicrobial activity
Barbour, E. K., Sharif, M. A., Sagherian, V. K., Habre, A. N., Talhouk, R., & Talhouk, S. N. (2004) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2004.02.027 · Cited by 245 · see citing works
The adverse health effects of synthetic cannabinoids with emphasis on psychosis-like effects
van Amsterdam, J., Brunt, T., & van den Brink, W. (2015) · Journal of Psychopharmacology · doi:10.1177/0269881114565142 · Cited by 244 · see citing works
GABAergic interneurons are the targets of cannabinoid actions in the human hippocampus
Katona, I., Sperlágh, B., Maglóczky, Z., Sántha, E., Köfalvi, A., Czirják, S., Mackie, K., Vizi, E. S., & Freund, T. F. (2000) · Neuroscience · doi:10.1016/s0306-4522(00)00286-4 · Cited by 242 · see citing works
Does Cannabidiol Protect Against Adverse Psychological Effects of THC?
Niesink, R. J. M., & van Laar, M. (2013) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2013.00130 · Cited by 241 · see citing works
Leweke, F. M., Giuffrida, A., Koethe, D., Schreiber, D., Nolden, B. M., Kranaster, L., Neatby, M. A., Schneider, M., Gerth, C. W., Hellmich, M., et al. (2007) · Schizophrenia Research · doi:10.1016/j.schres.2007.04.025 · Cited by 240 · see citing works
Therapeutic Potential of Cannabinoids in CNS Disease
Croxford, J. L. (2003) · CNS Drugs · doi:10.2165/00023210-200317030-00004 · Cited by 240 · see citing works
BRADY, C. M., Dasgupta, R., Dalton, C. M., Wiseman, O. J., Berkley, K. J., & Fowler, C. J. (2004) · Multiple Sclerosis Journal · doi:10.1191/1352458504ms1063oa · Cited by 240 · see citing works
The neuropsychopharmacology of cannabis: A review of human imaging studies
Bloomfield, M., Hindocha, C., Green, S. F., Wall, M. B., Lees, R., Petrilli, K., Costello, H., Ogunbiyi, O., Bossong, M. G., & Freeman, T. P. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.10.006 · Cited by 238 · see citing works
Mato, S., del Olmo, E., & Pazos, Á. (2003) · European Journal of Neuroscience · doi:10.1046/j.1460-9568.2003.02599.x · Cited by 232 · see citing works
Frisardi, V., Panza, F., Seripa, D., Farooqui, T., & Farooqui, A. A. (2011) · Progress in Lipid Research · doi:10.1016/j.plipres.2011.06.001 · Cited by 230 · see citing works
The endocannabinoid nervous system
Porter, A. C., & Felder, C. C. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00130-9 · Cited by 226 · see citing works
Hungund, B. L., Vinod, K. Y., Kassir, S. A., Basavarajappa, B. S., Yalamanchili, R., Cooper, T. B., Mann, J. J., & Arango, V. (2004) · Molecular Psychiatry · doi:10.1038/sj.mp.4001376 · Cited by 226 · see citing works
Cannabis and synaptic reprogramming of the developing brain
Bara, A., Ferland, J. N., Rompala, G. R., Szutorisz, H., & Hurd, Y. L. (2021) · Nature reviews. Neuroscience · doi:10.1038/s41583-021-00465-5 · Cited by 220 · see citing works
Reduced Cortical Cannabinoid 1 Receptor Messenger RNA and Protein Expression in Schizophrenia
Eggan, S. M., Hashimoto, T., & Lewis, D. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.7.772 · Cited by 219 · see citing works
Endocannabinoid signaling mediates oxytocin-driven social reward
Wei, D., Lee, D., Cox, C. D., Karsten, C. A., Peñagarikano, O., Geschwind, D. H., Gall, C. M., & Piomelli, D. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1509795112 · Cited by 218 · see citing works
Cannabinoid signaling in glial cells
Stella, N. (2004) · Glia · doi:10.1002/glia.20084 · Cited by 218 · see citing works
Marijuana and the Cannabinoids
ElSohly, M. A. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-947-9 · Cited by 217 · see citing works
Inhibition of GABAergic inhibitory postsynaptic currents by cannabinoids in rat corpus striatum
Szabó, B., Dorner, L., Pfreundtner, C., Nörenberg, W., & Starke, K. (1998) · Neuroscience · doi:10.1016/s0306-4522(97)00597-6 · Cited by 214 · see citing works
Cannabis and psychiatric disorders: it is not only addiction
Leweke, F. M., & Koethe, D. (2008) · Addiction Biology · doi:10.1111/j.1369-1600.2008.00106.x · Cited by 213 · see citing works
Deng, Y. P., Albin, R. L., Penney, J. B., Young, A. B., Anderson, K. D., & Reiner, A. (2004) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2004.02.005 · Cited by 213 · see citing works
Endocannabinoid Binding to the Cannabinoid Receptors: What Is Known and What Remains Unknown
Reggio, P. H. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710790980005 · Cited by 212 · see citing works
Endocannabinoid system in neurodegenerative disorders
Basavarajappa, B. S., Shivakumar, M., Joshi, V., & Subbanna, S. (2017) · Journal of Neurochemistry · doi:10.1111/jnc.14098 · Cited by 212 · see citing works
The Role of cannabinoids in neuroanatomic alterations in cannabis users.
Lorenzetti, V., Solowij, N., & Yücel, M. (2016) · Biological Psychiatry · doi:10.1016/j.biopsych.2015.11.013 · Cited by 208 · see citing works
“, 102 and 137 binding sites, respectively (31)].”
BackgroundInfluentialReview of the neurological benefits of phytocannabinoids
Maroon, J. C., & Bost, J. (2018) · Surgical Neurology International · doi:10.4103/sni.sni_45_18 · Cited by 208 · see citing works
Neuropathology of substance use disorders
Cadet, J. L., Bisagno, V., & Milroy, C. M. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1221-7 · Cited by 207 · see citing works
Wong, D. F., Kuwabara, H., Horti, A. G., Raymont, V., Brašić, J. R., Guevara, M. C., Ye, W., Dannals, R. F., Ravert, H. T., Nandi, A., et al. (2010) · NeuroImage · doi:10.1016/j.neuroimage.2010.04.034 · Cited by 204 · see citing works
The Endocannabinoid System, Cannabinoids, and Pain
Fine, P. G., & Rosenfeld, M. J. (2013) · Rambam Maimonides Medical Journal · doi:10.5041/rmmj.10129 · Cited by 203 · see citing works
Häuser, W., Finn, D. P., Kalso, E. A., Krcevski‐Škvarč, N., Kress, H. G., Morlion, B. J., Perrot, S., Schäfer, M., Wells, C., & Brill, S. (2018) · European Journal of Pain · doi:10.1002/ejp.1297 · Cited by 201 · see citing works
Miliano, C., Serpelloni, G., Rimondo, C., Mereu, M., Marti, M., & Luca, M. A. D. (2016) · Frontiers in Neuroscience · doi:10.3389/fnins.2016.00153 · Cited by 197 · see citing works
The Functional Neuroanatomy of Brain Cannabinoid Receptors
Breivogel, C. S., & Childers, S. R. (1998) · Neurobiology of Disease · doi:10.1006/nbdi.1998.0229 · Cited by 195 · see citing works
Cannabinoids and Pain: Sites and Mechanisms of Action
Starowicz, K., & Finn, D. P. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.05.003 · Cited by 192 · see citing works
Cannabis, cannabinoids and reproduction
Park, B., McPartland, J. M., & Glass, M. (2003) · Prostaglandins Leukotrienes and Essential Fatty Acids · doi:10.1016/j.plefa.2003.04.007 · Cited by 189 · see citing works
Self-citationKoethe, D., Llenos, I. C., Dulay, J. R., Hoyer, C., Torrey, Ε. F., Leweke, F. M., & Weis, S. (2007) · Journal of Neural Transmission · doi:10.1007/s00702-007-0660-5 · Cited by 187 · see citing works
Hillard, C. J., Weinlander, K. M., & Stuhr, K. L. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.11.020 · Cited by 186 · see citing works
Jutras‐Aswad, D., DiNieri, J. A., Harkany, T., & Hurd, Y. L. (2009) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-009-0027-z · Cited by 184 · see citing works
Exercise-induced endocannabinoid signaling is modulated by intensity
Raichlen, D. A., Foster, A. D., Seillier, A., Giuffrida, A., & Gerdeman, G. L. (2013) · European Journal of Applied Physiology · doi:10.1007/s00421-012-2495-5 · Cited by 181 · see citing works
- Authors
- Glass, M., Faull, R. L. M., & Dragunow, M.
- Affiliations
- University of Auckland (NZ)
- Corresponding author
- Faull, R.L.M
- Venue
- Neuroscience
- Publisher
- Elsevier BV
- Published
- 1997-02
- Volume
- 77
- Issue
- 2
- Pages
- 299-318
- ISSN
- 0306-4522 (ISSN-L)
- OpenAlex
- W2037811574
- Cited by
- 1,052
- References
- 68
- Citations by year
- 2026: 28 · 2025: 40 · 2024: 34 · 2023: 39 · 2022: 56 · 2021: 53 · 2020: 52 · 2019: 48 · 2018: 46 · 2017: 49 · 2016: 37 · 2015: 41 · 2014: 39 · 2013: 37 · 2012: 42
- FWCI
- 11.26
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Neuroscience (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology › Cannabis and Cannabinoid Research
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pharmacological Receptor Mechanisms and Effects
- Keywords
- cannabinoid receptors, human brain, receptor distribution, receptor density, fetal brain, neonatal brain, hippocampal formation, neocortex, cortical laminar organization, thalamus, basal ganglia, midbrain, spinal cord, globus pallidus internus, globus pallidus externus, ventral pallidum, striatum, amygdala, entorhinal cortex, hemispheric lateralization, CP55,940
- MeSH terms
- Adult, Aged, Aged, 80 and over, Autoradiography, Brain, Brain Chemistry, Brain Mapping, Cannabinoids, Coloring Agents, Female, Humans, Infant, Infant, Newborn, Male, Middle Aged, Myelin Sheath, Pregnancy, Receptors, Drug, Spinal Cord, Receptors, Cannabinoid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
